{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:02:44Z","timestamp":1770512564068,"version":"3.49.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T00:00:00Z","timestamp":1381708800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0077459","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T21:02:41Z","timestamp":1381784561000},"page":"e77459","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Erythropoietin Receptor Expression Is a Potential Prognostic Factor in Human Lung Adenocarcinoma"],"prefix":"10.1371","volume":"8","author":[{"given":"Anita","family":"R\u00f3zs\u00e1s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Berta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia","family":"Rojk\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3 Z.","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdolna","family":"Keszthelyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Kenessey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikt\u00f3ria","family":"L\u00e1szl\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Grusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mir Alireza","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szilvia","family":"T\u00f6r\u00f6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferenc","family":"R\u00e9nyi-V\u00e1mos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"Heged\u0171s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"D\u00f6me","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"T\u00f3v\u00e1ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1440-1843.2011.02095.x","article-title":"Pulmonary adenocarcinoma: a renewed entity in 2011","volume":"17","author":"H Kadara","year":"2012","journal-title":"Respirology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/JTO.0b013e3181758141","article-title":"Biological agents in non-small cell lung cancer: a review of recent advances and clinical results with a focus on epidermal growth factor receptor and vascular endothelial growth factor","volume":"3","author":"K Kelly","year":"2008","journal-title":"J Thorac Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrc2540","article-title":"The impact of O2 availability on human cancer","volume":"8","author":"JA Bertout","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref5","first-page":"716","article-title":"Targeting anemia in patients with lung cancer","volume":"1","author":"J Crawford","year":"2006","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0140-6736(09)60502-X","article-title":"Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials","volume":"373","author":"J Bohlius","year":"2009","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2174\/156652408785747979","article-title":"Erythropoietin in cancer: an update","volume":"8","author":"J T\u00f3v\u00e1ri","year":"2008","journal-title":"Curr Mol Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1073\/pnas.081275298","article-title":"Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models","volume":"98","author":"M Mittelman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.onc.1208205","article-title":"Chemosensitization by erythropoietin through inhibition of the NF-kappaB rescue pathway","volume":"24","author":"G Carvalho","year":"2005","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1634\/theoncologist.13-S3-16","article-title":"Erythropoietin receptors on tumor cells: what do they mean?","volume":"13","author":"J Fandrey","year":"2008","journal-title":"Oncologist"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-06-3061","article-title":"Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer","volume":"13","author":"P Saintigny","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1634\/stemcells.2006-0687","article-title":"Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity","volume":"25","author":"WM Brown","year":"2007","journal-title":"Stem Cells"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000092099","article-title":"Induction of signalling in non-erythroid cells by pharmacological levels of erythropoietin","volume":"3","author":"EA Dunlop","year":"2006","journal-title":"Neurodegener Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.lungcan.2005.10.020","article-title":"Pre-operative plasma erythropoietin concentration and survival following surgery for non-small cell lung cancer","volume":"51","author":"I Paul","year":"2006","journal-title":"Lung Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2010.02.003","article-title":"Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II\/III non-small-cell lung cancer","volume":"80","author":"D Rades","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12565-010-0081-7","article-title":"Erythropoietin-responsive sites in normal and malignant human lung tissues","volume":"85","author":"Y Yasuda","year":"2010","journal-title":"Anat Sci Int"},{"key":"ref17","first-page":"41","article-title":"Effects of hematopoietic growth factors on malignant nonhematopoietic cells","volume":"19","author":"WE Berdel","year":"1992","journal-title":"Semin Oncol"},{"key":"ref18","first-page":"92","article-title":"Effect of recombinant human erythropoietin on the growth of human tumor cell lines in vitro. Micro-titertec-tetrazolium assay","volume":"42","author":"D Mundt","year":"1992","journal-title":"Arzneimittelforschung"},{"key":"ref19","article-title":"Novella A, et al.","author":"V Rosti","year":"1993"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01714953","article-title":"Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro","volume":"63","author":"WE Berdel","year":"1991","journal-title":"Ann Hematol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/01.cad.0000180116.85912.69","article-title":"Hypoxia inducible factor-1: a novel target for cancer therapy","volume":"16","author":"VE Belozerov","year":"2005","journal-title":"Anti Cancer Drugs"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1158\/0008-5472.CAN-04-2498","article-title":"Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models","volume":"65","author":"J T\u00f3v\u00e1ri","year":"2005","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00066-008-1745-2","article-title":"Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels","volume":"184","author":"J L\u00f6vey","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1078-0432.993.11.3","article-title":"Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas","volume":"11","author":"K Dagnon","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood-2005-10-4066","article-title":"Anti-Epo receptor antibodies do not predict Epo receptor expression","volume":"107","author":"S Elliott","year":"2006","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1126\/science.257.5073.1138","article-title":"A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells","volume":"257","author":"Y Nakamura","year":"1992","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jim.2009.10.006","article-title":"Identification of a sensitive anti-erythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cells","volume":"352","author":"S Elliott","year":"2010","journal-title":"J Immunol Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/bjc.2012.42","article-title":"Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer","volume":"106","author":"M Aapro","year":"2012","journal-title":"Br J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.lungcan.2011.12.015","article-title":"Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses","volume":"76","author":"J Vansteenkiste","year":"2012","journal-title":"Lung Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/CCLM.1999.045","article-title":"Alterations of endothelial nucleotide levels by mycophenolic acid result in changes of membrane glycosylation and E-selectin expression","volume":"37","author":"P Bertalanffy","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1158\/1535-7163.223.3.3","article-title":"Nucleotide-based therapies targeting clusterin chemosensitize human lung adenocarcinoma cells both in vitro and in vivo","volume":"3","author":"LV July","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.cad.0000127664.66472.60","article-title":"Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models","volume":"15","author":"B Higgins","year":"2004","journal-title":"Anti Cancer Drugs"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00001813-200506000-00011","article-title":"Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine","volume":"16","author":"Y Wu","year":"2005","journal-title":"Anti Cancer Drugs"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/path.1124","article-title":"Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance","volume":"197","author":"B D\u00f6me","year":"2002","journal-title":"J Pathol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/jnen\/62.6.655","article-title":"A novel concept of glomeruloid body formation in experimental cerebral metastases","volume":"62","author":"B D\u00f6me","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2353\/ajpath.2009.090095","article-title":"Development of arterial blood supply in experimental liver metastases","volume":"175","author":"K Dezso","year":"2009","journal-title":"Am J Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/NEN.0b013e318233afd7","article-title":"Lack of angiogenesis in experimental brain metastases","volume":"70","author":"E Bugyik","year":"2011","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0077459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T09:46:03Z","timestamp":1688550363000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0077459"}},"subtitle":[],"editor":[{"given":"Hiromu","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,14]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0077459","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,14]]}}}